Jenner P - Search Results

1

Why do 'OFF' periods still occur during continuous drug delivery in Parkinson's disease?

Rota S, Urso D, van Wamelen DJ, Leta V, Boura I, Odin P, Espay AJ, Jenner P, Chaudhuri KR. Rota S, et al. Among authors: jenner p. Transl Neurodegener. 2022 Oct 13;11(1):43. doi: 10.1186/s40035-022-00317-x. Transl Neurodegener. 2022. PMID: 36229860 Free PMC article. Review.

2

Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?

Chaudhuri KR, Jenner P, Antonini A. Chaudhuri KR, et al. Among authors: jenner p. Mov Disord. 2019 Jun;34(6):816-819. doi: 10.1002/mds.27691. Epub 2019 Apr 14. Mov Disord. 2019. PMID: 30983023 No abstract available.

3

Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An update.

Leta V, Jenner P, Chaudhuri KR, Antonini A. Leta V, et al. Among authors: jenner p. Expert Opin Drug Saf. 2019 Dec;18(12):1203-1218. doi: 10.1080/14740338.2019.1681966. Epub 2019 Nov 5. Expert Opin Drug Saf. 2019. PMID: 31619083 Review.

4

Reply to: "Parkinson disease-associated dyskinesia in countries with low access to levodopa-sparing Regimens".

Chaudhuri KR, Jenner P, Antonini A. Chaudhuri KR, et al. Among authors: jenner p. Mov Disord. 2019 Dec;34(12):1930-1931. doi: 10.1002/mds.27871. Mov Disord. 2019. PMID: 31845760 No abstract available.

5

'Dopamine agonist Phobia' in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine.

Rota S, Boura I, Batzu L, Titova N, Jenner P, Falup-Pecurariu C, Chaudhuri KR. Rota S, et al. Among authors: jenner p. Expert Rev Neurother. 2020 Sep;20(9):953-965. doi: 10.1080/14737175.2020.1806059. Epub 2020 Sep 15. Expert Rev Neurother. 2020. PMID: 32755243 Review.

6

Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging Therapies.

Urso D, Chaudhuri KR, Qamar MA, Jenner P. Urso D, et al. Among authors: jenner p. CNS Drugs. 2020 Nov;34(11):1149-1163. doi: 10.1007/s40263-020-00769-7. Epub 2020 Nov 4. CNS Drugs. 2020. PMID: 33146817 Review.

7

Non motor subtypes and Parkinson's disease.

Sauerbier A, Jenner P, Todorova A, Chaudhuri KR. Sauerbier A, et al. Among authors: jenner p. Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S41-6. doi: 10.1016/j.parkreldis.2015.09.027. Epub 2015 Sep 11. Parkinsonism Relat Disord. 2016. PMID: 26459660 Free article. Review.

8

Non-motor features of Parkinson disease.

Schapira AHV, Chaudhuri KR, Jenner P. Schapira AHV, et al. Among authors: jenner p. Nat Rev Neurosci. 2017 Jul;18(7):435-450. doi: 10.1038/nrn.2017.62. Epub 2017 Jun 8. Nat Rev Neurosci. 2017. PMID: 28592904 Free article. Review.

9

Two hundred years since James Parkinson's essay on the shaking palsy-Have we made progress? Insights from the James Parkinson's 200 years course held in London, March 2017.

Chaudhuri KR, Jenner P. Chaudhuri KR, et al. Among authors: jenner p. Mov Disord. 2017 Sep;32(9):1311-1315. doi: 10.1002/mds.27104. Epub 2017 Aug 11. Mov Disord. 2017. PMID: 28799259 Review. No abstract available.

10

Dyskinesia Matters: But Not as Much as It Used to.

Chaudhuri KR, Jenner P, Antonini A. Chaudhuri KR, et al. Among authors: jenner p. Mov Disord. 2020 May;35(5):900-901. doi: 10.1002/mds.28047. Mov Disord. 2020. PMID: 32415717 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

770 results

Search Page